{"title": "Structural basis for the recognition of the 2019-nCoV by human ACE2", "doi": "10.1101/2020.02.19.956946", "citation_id": "2020.02.19.956946v1", "date": "2020-02-20", "laguage": "en", "journal_title": "bioRxiv", "first_page": "2020.02.19.956946", "abstract": "<p>Angiotensin-converting enzyme 2 (ACE2) has been suggested to be the cellular receptor for the new coronavirus (2019-nCoV) that is causing the coronavirus disease 2019 (COVID-19). Like other coronaviruses such as the SARS-CoV, the 2019-nCoV uses the receptor binding domain (RBD) of the surface spike glycoprotein (S protein) to engage ACE2. We most recently determined the structure of the full-length human ACE2 in complex with a neutral amino acid transporter B<sup>0</sup>AT1. Here we report the cryo-EM structure of the full-length human ACE2 bound to the RBD of the 2019-nCoV at an overall resolution of 2.9 \u00c5 in the presence of B<sup>0</sup>AT1. The local resolution at the ACE2-RBD interface is 3.5 \u00c5, allowing analysis of the detailed interactions between the RBD and the receptor. Similar to that for the SARS-CoV, the RBD of the 2019-nCoV is recognized by the extracellular peptidase domain (PD) of ACE2 mainly through polar residues. Pairwise comparison reveals a number of variations that may determine the different affinities between ACE2 and the RBDs from these two related viruses.</p>", "twitter_description": "Angiotensin-converting enzyme 2 (ACE2) has been suggested to be the cellular receptor for the new coronavirus (2019-nCoV) that is causing the coronavirus disease 2019 (COVID-19). Like other coronaviruses such as the SARS-CoV, the 2019-nCoV uses the receptor binding domain (RBD) of the surface spike glycoprotein (S protein) to engage ACE2. We most recently determined the structure of the full-length human ACE2 in complex with a neutral amino acid transporter BAT1. Here we report the cryo-EM structure of the full-length human ACE2 bound to the RBD of the 2019-nCoV at an overall resolution of 2.9 \u00c5 in the presence of BAT1. The local resolution at the ACE2-RBD interface is 3.5 \u00c5, allowing analysis of the detailed interactions between the RBD and the receptor. Similar to that for the SARS-CoV, the RBD of the 2019-nCoV is recognized by the extracellular peptidase domain (PD) of ACE2 mainly through polar residues. Pairwise comparison reveals a number of variations that may determine the different affinities between ACE2 and the RBDs from these two related viruses.", "full_text_html_url": "https://www.biorxiv.org/content/10.1101/2020.02.19.956946v1.full", "public_url": "https://www.biorxiv.org/content/10.1101/2020.02.19.956946v1", "abstract_html_url": "https://www.biorxiv.org/content/10.1101/2020.02.19.956946v1.abstract", "pdf_url": "https://www.biorxiv.org/content/biorxiv/early/2020/02/20/2020.02.19.956946.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory", "pisa": "biorxiv;2020.02.19.956946v1", "access_rights": "restricted", "authors": ["Renhong Yan", "Yuanyuan Zhang", "Yingying Guo", "Lu Xia", "Qiang Zhou"]}